Blood Clot Retrieval Devices Market: Market Size & Forecast 2026

Blood clot retrieval devices are endovascular instruments, predominantly stent retrievers and aspiration catheters, used to mechanically remove thrombi from cerebral and peripheral vessels during acute ischemic stroke and venous thromboembolism interventions. The global market is estimated at around USD 2.0 billion in 2025 and is projected to compound at roughly 11.5% per year through the next decade. Favorable randomized trial evidence, updated clinical guidelines recommending mechanical thrombectomy as standard of care for large vessel occlusion strokes, and improved hospital infrastructure underpin this expansion.

• •Global market valued near USD 2.0 billion in 2025 with ~11.5% CAGR forecast.
• •Device classes include stent retrievers, aspiration catheters, and combined aspiration-stent systems.
• •Mechanical thrombectomy is now guideline-recommended for eligible large vessel occlusion stroke patients.

Rising incidence of stroke, atrial fibrillation, deep vein thrombosis, and pulmonary embolism is creating a larger addressable patient population for mechanical thrombectomy. Expanded reimbursement, growth in comprehensive stroke centers, and ongoing technology improvements, such as nitinol microfabrication and larger-bore aspiration catheters, are shortening procedure times and improving first-pass recanalization rates. Aging populations in North America, Europe, and parts of Asia-Pacific further amplify procedure volumes.

• •Growing burden of ischemic stroke and venous thromboembolism fuels procedural demand.
• •Reimbursement expansions and new stroke center accreditation drive hospital adoption.
• •Device engineering advances improve clot engagement, trackability, and first-pass success.

By product type, the market splits into stent retrievers, aspiration catheters, and combined/penumbra-style systems, with aspiration technologies representing one of the fastest-growing segments because of favorable fluid mechanics and simplified workflows. By application, acute ischemic stroke accounts for the majority of revenue, while venous thromboembolism is an emerging high-growth segment. North America leads today due to established stroke networks and reimbursement, while Asia-Pacific is the fastest-growing region as countries expand neurointerventional capacity.

• •Aspiration catheters are gaining share alongside traditional stent retriever dominance.
• •Stroke applications lead; venous thromboembolism is a fast-growing adjacent segment.
• •North America leads in revenue; Asia-Pacific is the highest-growth regional market.

What are the recent trends and outlook?

Pipeline activity is heavy in microfabricated nitinol stent retrievers with patterned surfaces designed to improve clot engagement, as well as larger-bore aspiration catheters optimized for combined techniques. Adjacent venous applications are opening new revenue pools as catheter-directed thrombectomy becomes more widely adopted for pulmonary embolism and deep vein thrombosis. Over the medium term, expect continued double-digit growth, gradual margin pressure from competition, and steady penetration into emerging healthcare systems.

• •Innovation focuses on patterned nitinol stent retrievers and large-bore aspiration catheters.
• •Venous thromboembolism indications are emerging as a significant growth frontier.
• •Sustained double-digit growth is expected as access expands in emerging markets.